| 1 |
33481008 | circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway. | 2021 Jul 3 |
3 |
| 2 |
33556340 | TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer. | 2021 Apr |
8 |
| 3 |
34022297 | Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8. | 2021 Aug 5 |
2 |
| 4 |
34600241 | Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines. | 2021 Nov 1 |
7 |
| 5 |
32278794 | Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells. | 2020 Jul |
6 |
| 6 |
32354736 | Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis. | 2020 Aug |
2 |
| 7 |
32447047 | Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling. | 2020 Oct |
4 |
| 8 |
32628454 | Ultrasound-Augmented Phase Transition Nanobubbles for Targeted Treatment of Paclitaxel-Resistant Cancer. | 2020 Aug 19 |
3 |
| 9 |
33370338 | The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer. | 2020 |
3 |
| 10 |
30578561 | Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome. | 2019 Mar |
3 |
| 11 |
32026322 | Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers. | 2019 Dec |
2 |
| 12 |
28771725 | TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells. | 2018 Mar |
16 |
| 13 |
29486738 | Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8. | 2018 Feb 27 |
12 |
| 14 |
29531019 | Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies. | 2018 Jun |
1 |
| 15 |
30322956 | Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity. | 2018 Oct 15 |
1 |
| 16 |
30355931 | Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis. | 2018 |
7 |
| 17 |
28108630 | Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer. | 2017 Mar |
1 |
| 18 |
28242239 | Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro. | 2017 Jun |
6 |
| 19 |
28440494 | Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer. | 2017 Jun |
6 |
| 20 |
26636884 | Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance. | 2016 Jan 11 |
3 |
| 21 |
27059733 | Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation. | 2016 Sep |
5 |
| 22 |
27262815 | PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production. | 2016 May 30 |
2 |
| 23 |
25388329 | Activation of TLR-4 to produce tumour necrosis factor-α in neuropathic pain caused by paclitaxel. | 2015 Aug |
3 |
| 24 |
25681684 | Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. | 2015 Apr |
1 |
| 25 |
25868824 | Paclitaxel induces acute pain via directly activating toll like receptor 4. | 2015 Mar 11 |
5 |
| 26 |
25998620 | The Role of TLR4 in Chemotherapy-Driven Metastasis. | 2015 Jun 15 |
1 |
| 27 |
26424893 | The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4. | 2015 Sep 30 |
8 |
| 28 |
24420921 | Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions. | 2014 Feb 15 |
2 |
| 29 |
24452475 | Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. | 2014 Jan 23 |
6 |
| 30 |
24527095 | TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro. | 2014 Mar |
5 |
| 31 |
25274031 | Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. | 2014 Oct 1 |
7 |
| 32 |
25550688 | Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells. | 2014 |
1 |
| 33 |
23720768 | TLR4 is a novel determinant of the response to paclitaxel in breast cancer. | 2013 Aug |
9 |
| 34 |
24371445 | Combinations of TLR ligands: a promising approach in cancer immunotherapy. | 2013 |
1 |
| 35 |
22533866 | Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells. | 2012 Apr 25 |
1 |
| 36 |
22743248 | Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. | 2012 Sep |
5 |
| 37 |
21091668 | Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells. | 2011 Feb |
1 |
| 38 |
19200169 | Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. | 2009 Feb |
7 |
| 39 |
19619321 | KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells. | 2009 Jul 20 |
1 |
| 40 |
19826413 | TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. | 2009 Dec 10 |
5 |
| 41 |
18650420 | Paclitaxel binding to human and murine MD-2. | 2008 Oct 10 |
3 |
| 42 |
18688857 | Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel. | 2008 Oct 15 |
4 |
| 43 |
18977229 | Taxanes inhibit human TLR4 signaling by binding to MD-2. | 2008 Nov 26 |
1 |
| 44 |
16585214 | TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. | 2006 Apr 1 |
1 |
| 45 |
15829295 | Differential induction of apoptosis by LPS and taxol in monocytic cells. | 2005 May |
1 |
| 46 |
12139759 | MyD88 is involved in the signalling pathway for Taxol-induced apoptosis and TNF-alpha expression in human myelomonocytic cells. | 2002 Aug |
1 |
| 47 |
11357875 | Toll-like receptors; their physiological role and signal transduction system. | 2001 Apr |
1 |